Table 2. Relationships between C0 and adverse events.
Hand foot syndrome | Thrombocytopenia | Hypertention | Hypothiroidism | Fatigue | ||||||
---|---|---|---|---|---|---|---|---|---|---|
(G0 vs ≥ G1) | (G0 vs ≥ G1) | (G0 vs ≥ G1) | (G0 vs ≥ G1) | (G0 vs ≥ G1) | ||||||
Median | p | Median | p | Median | p | Median | p | Median | p | |
SU C0 | 48.3 vs 89.5 | <0.01 | 50.8 vs 89.5 | 0.02 | 54.8 vs 65.8 | 0.90 | 50.8 vs 71.2 | 0.08 | 49.6 vs 70.1 | 0.06 |
DSU C0 | 12.9 vs 15.2 | 0.88 | 11.9 vs 16.2 | 0.44 | 11.7 vs 15.3 | 0.82 | 11.7 vs 16.2 | 0.55 | 11.7 vs 15.7 | 0.64 |
SU + DSU C0 | 64.2 vs 75.2 | <0.01 | 64.4 vs 75.2 | 0.01 | 67.2 vs 77.5 | 0.82 | 64.4 vs 94.1 | 0.07 | 64.3 vs 91.5 | 0.16 |
Abbreviations: G, grade; SU, sunitinib; C0, predose drug concentration; DSU, N-desetyl sunitinib.